A point mutation in the bile acid biosynthetic enzyme sterol 27-hydroxylase in a family with cerebrotendinous xanthomatosis
- PMID: 8006521
A point mutation in the bile acid biosynthetic enzyme sterol 27-hydroxylase in a family with cerebrotendinous xanthomatosis
Abstract
Cerebrotendinous xanthomatosis (CTX) is a rare familial disorder characterized by progressive neurological dysfunction, atherosclerosis, and xanthomas with sterol storage in the nervous system, vessels, and tendons. Increased serum cholestanol, derived from intermediates of cholesterol catabolism, may possibly be a major cause of the disease. An examination was made of the cDNA encoding cytochrome P450 sterol 27-hydroxylase (CYP27) in hepatic mitochondria, considered a defective enzyme inducing CTX, in a Japanese housewife afflicted with CTX and her family. The proposita and one of her brothers, who also had CTX symptoms and hypercholestanolemia, were found to be homozygotic, carrying a point mutation in the CYP27 gene at Arg104 (CGG) to Trp104 (TGG). The mutant position has a 100% conserved positive charge in all known vertebrate cytochrome P450s and even in bacterial cytochrome P450cam. The mother of the proposita and another brother were both free of CTX symptoms and were heterozygotic for the mutation, although their plasma cholesterol increased moderately. An increase in plasma cholestanol alone would, thus, not appear to be a direct cause of sterol storage in CTX, while CTX is strongly suggested to be caused by defects in both alleles of the CYP27 gene.
Similar articles
-
Identification of new mutations in sterol 27-hydroxylase gene in Japanese patients with cerebrotendinous xanthomatosis (CTX).J Lipid Res. 1994 Jun;35(6):1031-9. J Lipid Res. 1994. PMID: 7915755
-
A novel mutation in the cytochrome P450(27) (CYP27) gene caused cerebrotendinous xanthomatosis in a Japanese family.J Lipid Res. 1996 Mar;37(3):631-9. J Lipid Res. 1996. PMID: 8728324
-
Mutations in the bile acid biosynthetic enzyme sterol 27-hydroxylase underlie cerebrotendinous xanthomatosis.J Biol Chem. 1991 Apr 25;266(12):7779-83. J Biol Chem. 1991. PMID: 2019602 Free PMC article.
-
Sterol 27-hydroxylase deficiency: a rare cause of xanthomas in normocholesterolemic humans.Trends Endocrinol Metab. 2000 Jul;11(5):180-3. doi: 10.1016/s1043-2760(00)00255-1. Trends Endocrinol Metab. 2000. PMID: 10856919 Review.
-
Cerebrotendinous xanthomatosis: clinical course, genotypes and metabolic backgrounds.Clin Invest Med. 2004 Feb;27(1):42-50. Clin Invest Med. 2004. PMID: 15061585 Review.
Cited by
-
Natural history of neurological abnormalities in cerebrotendinous xanthomatosis.J Inherit Metab Dis. 2018 Jul;41(4):647-656. doi: 10.1007/s10545-018-0152-9. Epub 2018 Feb 26. J Inherit Metab Dis. 2018. PMID: 29484516 Review.
-
Review of progress in sterol oxidations: 1987-1995.Lipids. 1996 May;31(5):453-87. doi: 10.1007/BF02522641. Lipids. 1996. PMID: 8727640 Review.
-
Fine-mapping, mutation analyses, and structural mapping of cerebrotendinous xanthomatosis in U.S. pedigrees.J Lipid Res. 2001 Feb;42(2):159-69. J Lipid Res. 2001. PMID: 11181744 Free PMC article.
-
Mutations producing premature termination of translation and an amino acid substitution in the sterol 27-hydroxylase gene cause cerebrotendinous xanthomatosis associated with parkinsonism.J Neurol Neurosurg Psychiatry. 1999 Aug;67(2):195-8. doi: 10.1136/jnnp.67.2.195. J Neurol Neurosurg Psychiatry. 1999. PMID: 10406988 Free PMC article.
-
Cerebrotendinous Xanthomatosis patients with late diagnosed in single orthopedic clinic: two novel variants in the CYP27A1 gene.Orphanet J Rare Dis. 2024 Feb 9;19(1):53. doi: 10.1186/s13023-024-03082-4. Orphanet J Rare Dis. 2024. PMID: 38336741 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources